SIR 2025
Peripheral Arterial Disease (PAD)
Scientific Session
Subhash Gutti, MD (he/him/his)
PGY-2
RUSH VIR, United States
Aesha Patel, MD
Resident Phyisican
Rush University Medical Center, United States
Sreekumar Madassery, MD, FSIR
Physician
Rush University Medical Center, United States
Ulku Turba, MD, FSIR
Professor
Rush University Medical Center, United States
Bulent Arslan, MD, FSIR
Professor and Interim Chair
Rush University Medical Center, United States
Between July 2012 and September 2024, our institution utilized retrograde peroneal access with arterial flossing for 20 cases (17 SAFARI, 3 true-lumen flossing). Technically successful revascularization was achieved in 95% of cases. Hemostasis was achieved at all access sites in 100% of cases. Balloon angioplasty was utilized to achieve peroneal artery hemostasis in 80% of cases. In addition to balloon tamponade of the access site, some cases utilized additional hemostatic techniques including Gelfoam of the needle tract. There was only 1 case involving an immediate complication (distal thrombus which resolved following catheter-directed thrombolysis).
For the 18 patients who reached the 6-month follow-up period, primary patency was 50%, amputation-free survival rate was 78%, and mortality rate was 0%. These results are particularly noteworthy, given this cohort was considered to have no alternative revascularization options at the time of intervention.
Conclusion: For CLTI patients lacking alternative tibio-pedal access targets, retrograde peroneal access with flossing technique can be a safe and effective limb-salvage option with durable outcomes. Operators can mitigate risks of retrograde peroneal access by optimizing access technique and utilizing balloon angioplasty for hemostasis. Further long-term data on peroneal access is necessary for a more comprehensive outcomes analysis.